Back

Results - Announcements

Sales rise 36.61% to Rs 61.23 crore

Kilitch Drugs (India) consolidated net profit rises 189.69% in the March 2025 quarter

20-May-2025, 07:46
Net profit of Kilitch Drugs (India) rose 189.69% to Rs 10.40 crore in the quarter ended March 2025 as against Rs 3.59 crore during the previous quarter ended March 2024. Sales rose 36.61% to Rs 61.23 crore in the quarter ended March 2025 as against Rs 44.82 crore during the previous quarter ended March 2024.

For the full year,net profit rose 82.88% to Rs 26.70 crore in the year ended March 2025 as against Rs 14.60 crore during the previous year ended March 2024. Sales rose 28.47% to Rs 198.32 crore in the year ended March 2025 as against Rs 154.37 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	61.23	44.82	37	198.32	154.37	28
OPM %	23.83	15.80	-	15.87	15.64	-
PBDT	14.69	6.23	136	37.58	22.70	66
PBT	13.84	5.30	161	34.47	19.35	78
NP	10.40	3.59	190	26.70	14.60	83